CLOs on the Move

Indivior

www.indivior.com

 
The world leader in addiction treatment with over 20 years of experience and a patient-focused approach. We didn`t become the world leader in addiction treatment overnight. Our endeavor started small, with one singular focus – to intimately understand the journey of individuals suffering with addiction. People with addiction are often stereotyped and discounted, creating an environment where many are under-diagnosed, undertreated and under-supported. They`re often unaware of their treatment options, have limited access to treatment, or simply don`t seek it out because they`re afraid of being stigmatized. Since our inception, we have actively partnered with healthcare professionals, the public health community, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.indivior.com
  • 10710 Midlothian Turnpike Suite 430
    Richmond, VA USA 23235
  • Phone: 804.379.1090

Executives

Name Title Contact Details
Stephen Kim
General Counsel, Commercial Profile
Randy Batenhorst
Senior Vice President - Regulatory Affairs Profile
Jessica Colon
VP, Deputy Compliance Officer Profile
Javier Rodriguez
Chief Legal Officer Profile
Javier Rodriguez
Chief Legal Officer Profile

Similar Companies

Synchem

Synchem, Inc. is a Elk Grove Village, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Precision Diagnostics

Precision Diagnostics, a leader in clinical laboratory testing and medication adherence monitoring, is transforming healthcare through the delivery of comprehensive, insightful clinical data that can help improve patient outcomes and manage costs. Spec...

Targanta Therapeutics

Targanta Therapeutics Corp. is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Innopsys

Innopsys is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zymergen

Founded in 2013 and based in the San Francisco Bay Area, Zymergen integrates automation, machine learning, and genomics to rapidly accelerate the pace of scientific advancement. We treat the genome as a search space, leveraging machine learning to make discoveries far beyond the bounds of human intuition. In doing so, we deliver economic value, material diversity and performance capabilities not previously possible.